Literature DB >> 26356641

The roles and clinical significance of microRNAs in cervical cancer.

Fenfen Wang1, Baohua Li1, Xing Xie2.   

Abstract

Cervical carcinogenesis induced by persistent human papillomavirus (HPV) infection represents a stepwise progression from precursors to invasive cervical cancer. Accumulated evidence has shown aberrant expression of microRNAs (miRNAs) in cervical cancer tissues and cells. Further studies reveal that miRNAs play key roles in the initiation and progression of cervical cancer, via specific signaling pathways, including E6-p53, E7-pRb, phosphoinositide-3 kinase (PI3K)-Akt, Notch, Wnt/β-catenin, and Hedgehog pathways. Some studies demonstrate that miRNAs might serve as biomarkers or therapeutic targets, presenting a potential prospect in clinical practice. All results provide new insights into the function of miRNAs and the pathogenesis of cervical cancer induced by viral oncoproteins. New approaches for miRNA-based prevention and management for cervical cancer will be developed in the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26356641     DOI: 10:14670/HH-11-666

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  16 in total

1.  MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.

Authors:  Shanzong Wang; Baohong Gao; Hailin Yang; Xuejian Liu; Xia Wu; Weijuan Wang
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

2.  MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.

Authors:  Fanxu Meng; Jian Ou; Jinyu Liu; Xindi Li; Yanli Meng; Ling Yan; Ping Deng; Baosheng Sun
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

3.  MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.

Authors:  Hui Yang; Xiao-Li Wu; Kai-Hua Wu; Rong Zhang; Li-Li Ju; Ying Ji; Yan-Wei Zhang; Song-Lin Xue; Ye-Xin Zhang; Yong-Feng Yang; Min-Min Yu
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 4.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

5.  miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.

Authors:  Elgar Susanne Quabius; Immanuel Merz; Tibor Görögh; Jürgen Hedderich; Jochen Haag; Christoph Röcken; Petra Ambrosch; Markus Hoffmann
Journal:  Papillomavirus Res       Date:  2017-06-16

6.  MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.

Authors:  Ke Fu; Ling Zhang; Rui Liu; Qi Shi; Xue Li; Min Wang
Journal:  World J Surg Oncol       Date:  2020-05-30       Impact factor: 2.754

7.  miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1.

Authors:  Rui Yao; Huzhong Zheng; Liqun Wu; Pingsheng Cai
Journal:  Onco Targets Ther       Date:  2018-12-11       Impact factor: 4.147

8.  Significance of miR-141 and miR-340 in cervical squamous cell carcinoma.

Authors:  Wenting Li; Bo Yang; Yiqun Li; Cuicui Wang; Xinzhi Fang
Journal:  Open Med (Wars)       Date:  2021-06-16

9.  MiR-96 enhances cellular proliferation and tumorigenicity of human cervical carcinoma cells through PTPN9.

Authors:  Xiaoping Ma; Wentian Shi; Lina Peng; Xuying Qin; Yuzuo Hui
Journal:  Saudi J Biol Sci       Date:  2018-02-07       Impact factor: 4.219

10.  Loss of miR-143 and miR-145 in condyloma acuminatum promotes cellular proliferation and inhibits apoptosis by targeting NRAS.

Authors:  Xiaoyan Liu; Yu Zhang; Su Wang; Guoying Liu; Liming Ruan
Journal:  R Soc Open Sci       Date:  2018-08-29       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.